Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
GlaxoSmithKline |
---|---|
Information provided by: | GlaxoSmithKline |
ClinicalTrials.gov Identifier: | NCT00728208 |
This study will consist of 4 parallel cohorts of healthy volunteers(elderly male, elderly female, young male and young female. Subjects will receive either GSK372475 1.5mg or placebo for 28 days
Condition | Intervention | Phase |
---|---|---|
Depression |
Drug: GSK372475 |
Phase I |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Single Blind (Subject), Parallel Assignment, Pharmacokinetics Study |
Official Title: | A Placebo-controlled, Single-blind, Randomised, Parallel Group, 28-day Repeat Dose Study to Investigate the Tolerability, Safety and Steady State Pharmacokinetics of GSK372475 in Healthy Young and Elderly, Male and Female Subjects |
Enrollment: | 66 |
Study Start Date: | July 2008 |
Study Completion Date: | December 2008 |
Primary Completion Date: | December 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
GSK372475: Experimental
Drug
|
Drug: GSK372475
drug
|
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Responsible Party: | GSK ( Study Director ) |
Study ID Numbers: | 105467 |
Study First Received: | July 31, 2008 |
Last Updated: | August 20, 2009 |
ClinicalTrials.gov Identifier: | NCT00728208 History of Changes |
Health Authority: | Germany: Federal Institute for Drugs and Medical Devices |
GSK372475 Elderly Young Randomised |
Depression Healthy Depressive Disorder Behavioral Symptoms |
Depression Behavioral Symptoms |